Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Gefitinib With or Without Carboplatin and Paclitaxel in Treating Older Patients With Unresectable or Metastatic Non-Small Cell Lung Cancer

This study has been completed.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Alliance for Clinical Trials in Oncology Identifier:
First received: June 5, 2003
Last updated: August 12, 2016
Last verified: August 2016